Merck (MRK) Minority Interest (2009 - 2026)

Merck (MRK) has reported Minority Interest for 18 consecutive years, with $51.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Minority Interest fell 23.88% year-over-year to $51.0 million in Q2 2026; TTM through Jun 2026 was $51.0 million, a 23.88% decrease from a year earlier, with the FY2025 full-year figure at $56.0 million, down 5.08% from the prior year.
• Minority Interest was $51.0 million for Q2 2026 at Merck, down from $53.0 million in the prior quarter.
• Over five years, Minority Interest peaked at $75.0 million in Q2 2022 and troughed at $49.0 million in Q2 2023.
• A 5-year average of $61.0 million and a median of $59.5 million in 2024 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest slumped 34.67% in 2023 and surged 34.69% in 2024, its largest moves.
• Over 5 years, Minority Interest stood at $67.0 million in 2022, then slipped by 19.4% to $54.0 million in 2023, then increased by 9.26% to $59.0 million in 2024, then slipped by 5.08% to $56.0 million in 2025, then dropped by 8.93% to $51.0 million in 2026.
• The last three Minority Interest figures came in at $51.0 million (Q2 2026), $53.0 million (Q1 2026), and $56.0 million (Q4 2025), per Business Quant data.